No Data
No Data
No Data
No Data
No Data
Embecta to Participate in Investor Events
PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in
GlobeNewswireMay 2 05:00
Embecta to Report Fiscal Second Quarter 2024 Financial Results
PARSIPPANY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal
GlobeNewswireApr 24 05:00
Revelyst Announces Chief Supply Chain Officer
Business WireApr 23 19:00
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
TipRanksApr 1 19:30
Embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at
GlobeNewswireMar 6 19:00
Embecta(EMBC.US) Director Buys US$32,500 in Common Stocks
$Embecta(EMBC.US)$ Director Melcher David F purchased 2,000 shares of Common Stocks on Feb 12, 2024 at an average price of $16.25 for a total value of $32,500.Source: Announcement What is statement of
Futu NewsFeb 13 08:49
No Data
No Data